Compare Morgan Stanley (MS) vs Procter & Gamble Co (PG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Morgan Stanley vs Procter & Gamble Co — how do they compare? Morgan Stanley trades at $190.02 (market cap $294.39B), while Procter & Gamble Co trades at $151.23 (market cap $349.77B). The key difference: Procter & Gamble Co is the larger of the two by market cap, and Procter & Gamble Co pays the higher dividend (2.89%). Which is the better fit depends on your goals — on Pluang, investors hold Morgan Stanley for 92 Days and Procter & Gamble Co for 131 Days on average.
| MS | PG | |
|---|---|---|
Market Cap | $294.39B | $349.77B |
Volume | 5,836,423 | 10,055,825 |
Sector | Financials | Consumer Staples |
52-Week High | $228.42 | $167.18 |
52-Week Low | $151.86 | $138.10 |
Typical Hold Time | 92 Days | 131 Days |
Enterprise Value | $660.04B | $375.61B |
Dividend Yield | 2.45% | 2.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Morgan Stanley (MS) trades at $187.41, down 1.21% on the day, with a bearish technical signal from moving averages. The company shows strong fundamental momentum, with revenue growing to $66.0 billion in 2025 and net income reaching $16.9 billion, alongside three consecutive quarterly EPS beats. Analysts maintain a bullish stance with a $229.25 consensus price target, citing growth in wealth management and AI financing.
The outlook is positive given earnings momentum and strategic growth areas, but risks include volatile cash flows from operations and rising debt-to-asset ratios. The stock offers potential upside to analyst targets if execution continues, though macroeconomic and capital markets volatility pose headwinds.
Procter & Gamble (PG) trades at $150.59, up 1.87% with bullish technical momentum as it approaches resistance near $151. The company demonstrates strong fundamentals with consistent earnings beats, 18.44% net margins, and robust cash flow generation. Recent partnership with the WNBA highlights strategic brand expansion while maintaining a 69-year dividend growth streak. Valuation metrics show premium multiples relative to peers, with P/E at 22.75 and P/S at 4.19.
PG offers stable growth with dividend reliability but faces valuation concerns amid modest revenue expansion. The consensus price target of $160.13 suggests 6.3% upside potential, supported by 53 analyst ratings favoring Buy (52.8%). Key risks include premium valuation pressure and competitive market dynamics. The stock presents a defensive investment opportunity with consistent cash flow generation in consumer staples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Read more on MS →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
